N-acetylcysteine Effects on Tetrahydrocannabinol

NCT02335060 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Feasibility pilot was completed

Conditions

Healthy

Interventions

DRUG: Delta-9-THC
DRUG: N-acetylcysteine
DRUG: Placebo
DRUG: Placebo

Sponsor

Yale University